1
|
Soria LR, Allegri G, Melck D, Pastore N,
Annunziata P, Paris D, Polishchuk E, Nusco E, Thöny B, Motta A, et
al: Enhancement of hepatic autophagy increases ureagenesis and
protects against hyperammonemia. Proc Natl Acad Sci U S A.
115:391–396. 2018.PubMed/NCBI View Article : Google Scholar
|
2
|
Ballantyne LL, Sin YY, St Amand T, Si J,
Goossens S, Haenebalcke L, Haigh JJ, Kyriakopoulou L, Schulze A and
Funk CD: Strategies to rescue the consequences of inducible
arginase-1 deficiency in mice. PLoS One.
10(e0125967)2015.PubMed/NCBI View Article : Google Scholar
|
3
|
Braissant O: Current concepts in the
pathogenesis of urea cycle disorders. Mol Genet Metab. 100 (Suppl
1):S3–S12. 2010.PubMed/NCBI View Article : Google Scholar
|
4
|
Unsinn C, Das A, Valayannopoulos V, Thimm
E, Beblo S, Burlina A, Konstantopoulou V, Mayorandan S, de Lonlay
P, Rennecke J, et al: Clinical course of 63 patients with neonatal
onset urea cycle disorders in the years 2001-2013. Orphanet J Rare
Dis. 11(116)2016.PubMed/NCBI View Article : Google Scholar
|
5
|
Summar ML, Dasouki MJ, Schofield PJ,
Krishnamani MR, Vnencak-Jones C, Tuchman M, Mao J and Phillips JA
3rd: Physical and linkage mapping of human carbamyl phosphate
synthetase I (CPS1) and reassignment from 2p to 2q35. Cytogenet
Cell Genet. 71:266–267. 1995.PubMed/NCBI View Article : Google Scholar
|
6
|
Haberle J, Schmidt E, Pauli S, Rapp B,
Christensen E, Wermuth B and Koch HG: Gene structure of human
carbamylphosphate synthetase 1 and novel mutations in patients with
neonatal onset. Hum Mutat. 21(444)2003.PubMed/NCBI View Article : Google Scholar
|
7
|
Funghini S, Donati MA, Pasquini E,
Zammarchi E and Morrone A: Structural organization of the human
carbamyl phosphate synthetase I gene (CPS1) and identification of
two novel genetic lesions. Hum Mutat. 22:340–341. 2003.PubMed/NCBI View Article : Google Scholar
|
8
|
Summar ML, Hall LD, Eeds AM, Hutcheson HB,
Kuo AN, Willis AS, Rubio V, Arvin MK, Schofield JP and Dawson EP:
Characterization of genomic structure and polymorphisms in the
human carbamyl phosphate synthetase I gene. Gene. 311:51–57.
2003.PubMed/NCBI View Article : Google Scholar
|
9
|
Singh RH: Nutritional management of
patients with urea cycle disorders. J Inherit Metab Dis.
30:880–887. 2007.PubMed/NCBI View Article : Google Scholar
|
10
|
World Medical Association. World medical
association declaration of helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194.
2013.PubMed/NCBI View Article : Google Scholar
|
11
|
Jin D, Yu T, Zhang L, Wang T, Hu J, Wang Y
and Yang XA: Novel NFU1 variants induced MMDS behaved as special
leukodystrophy in chinese sufferers. J Mol Neurosci. 62:255–261.
2017.PubMed/NCBI View Article : Google Scholar
|
12
|
Peng F, Zhong L, Zhang B, Zou R, Nie S,
Tian X, Deng S and He X: Successful application of next-generation
sequencing for pre-natal diagnosis in a pedigree with chronic
granulomatosis disease. Exp Ther Med. 17:2931–2936. 2019.PubMed/NCBI View Article : Google Scholar
|
13
|
Chen Q, Bao H, Wu H, Zhao S, Huang S and
Zhao F: Diagnosis of cobalamin C deficiency with renal abnormality
from onset in a Chinese child by next generation sequencing: A case
report. Exp Ther Med. 14:3637–3643. 2017.PubMed/NCBI View Article : Google Scholar
|
14
|
Zytkovicz TH, Fitzgerald EF, Marsden D,
Larson CA, Shih VE, Johnson DM, Strauss AW, Comeau AM, Eaton RB and
Grady GF: Tandem mass spectrometric analysis for amino, organic,
and fatty acid disorders in newborn dried blood spots: A two-year
summary from the new England newborn screening program. Clin Chem.
47:1945–1955. 2001.PubMed/NCBI
|
15
|
Adzhubei I, Jordan DM and Sunyaev SR:
Predicting functional effect of human missense mutations using
PolyPhen-2. Curr Protoc Hum Genet. 7(20)2013.PubMed/NCBI View Article : Google Scholar
|
16
|
Kumar P, Henikoff S and Ng PC: Predicting
the effects of coding non-synonymous variants on protein function
using the SIFT algorithm. Nat Protoc. 4:1073–1081. 2009.PubMed/NCBI View Article : Google Scholar
|
17
|
Choi Y, Sims GE, Murphy S, Miller JR and
Chan AP: Predicting the functional effect of amino acid
substitutions and indels. PLoS One. 7(e46688)2012.PubMed/NCBI View Article : Google Scholar
|
18
|
Choi Y and Chan AP: PROVEAN web server: A
tool to predict the functional effect of amino acid substitutions
and indels. Bioinformatics. 31:2745–2747. 2015.PubMed/NCBI View Article : Google Scholar
|
19
|
Schwarz JM, Cooper DN, Schuelke M and
Seelow D: MutationTaster2: Mutation prediction for the
deep-sequencing age. Nat Methods. 11:361–362. 2014.PubMed/NCBI View Article : Google Scholar
|
20
|
de Cima S, Polo LM, Diez-Fernandez C,
Martínez AI, Cervera J, Fita I and Rubio V: Structure of human
carbamoyl phosphate synthetase: Deciphering the on/off switch of
human ureagenesis. Sci Rep. 5(16950)2015.PubMed/NCBI View Article : Google Scholar
|
21
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American college
of medical genetics and genomics and the association for molecular
pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
|
22
|
Kurokawa K, Yorifuji T, Kawai M, Momoi T,
Nagasaka H, Takayanagi M, Kobayashi K, Yoshino M, Kosho T, Adachi
M, et al: Molecular and clinical analyses of Japanese patients with
carbamoylphosphate synthetase 1 (CPS1) deficiency. J Hum Genet.
2:349–354. 2007.PubMed/NCBI View Article : Google Scholar
|
23
|
Liu D, Wang Y, Yang XA and Liu D: De novo
mutation of paternal IGF2 gene causing silver-russell syndrome in a
sporadic patient. Front Genet. 8(105)2017.PubMed/NCBI View Article : Google Scholar
|
24
|
Haberle J, Boddaert N, Burlina A,
Chakrapani A, Dixon M, Huemer M, Karall D, Martinelli D, Crespo PS,
Santer R, et al: Suggested guidelines for the diagnosis and
management of urea cycle disorders. Orphanet J Rare Dis.
7(32)2012.PubMed/NCBI View Article : Google Scholar
|
25
|
Yang X, Shi J, Lei H, Xia B and Mu D:
Neonatal-onset carbamoyl phosphate synthetase I deficiency: A case
report. Medicine (Baltimore). 96(e7365)2017.PubMed/NCBI View Article : Google Scholar
|
26
|
Ali EZ, Khalid MK, Yunus ZM, Yakob Y, Chin
CB, Abd Latif K and Hock NL: Carbamoylphosphate synthetase 1 (CPS1)
deficiency: Clinical, biochemical, and molecular characterization
in Malaysian patients. Eur J Pediatr. 175:339–346. 2016.PubMed/NCBI View Article : Google Scholar
|
27
|
Haberle J, Burlina A, Chakrapani A, Dixon
M, Karall D, Lindner M, Mandel H, Martinelli D, Pintos-Morell G,
Santer R, et al: Suggested guidelines for the diagnosis and
management of urea cycle disorders: First revision. J Inherit Metab
Dis. 42:1192–1230. 2019.PubMed/NCBI View Article : Google Scholar
|
28
|
Ono H, Suto T, Kinoshita Y, Sakano T,
Furue T and Ohta T: A case of carbamoyl phosphate synthetase 1
deficiency presenting symptoms at one month of age. Brain Dev.
31:779–781. 2009.PubMed/NCBI View Article : Google Scholar
|
29
|
Klaus V, Vermeulen T, Minassian B,
Israelian N, Engel K, Lund AM, Roebrock K, Christensen E and
Häberle J: Highly variable clinical phenotype of carbamylphosphate
synthetase 1 deficiency in one family: An effect of allelic
variation in gene expression? Clin Genet. 76:263–269.
2009.PubMed/NCBI View Article : Google Scholar
|
30
|
Foschi FG, Morelli MC, Savini S,
Dall'Aglio AC, Lanzi A, Cescon M, Ercolani G, Cucchetti A, Pinna AD
and Stefanini GF: Urea cycle disorders: A case report of a
successful treatment with liver transplant and a literature review.
World J Gastroenterol. 21:4063–4068. 2015.PubMed/NCBI View Article : Google Scholar
|
31
|
Kasahara M, Sakamoto S, Shigeta T, Fukuda
A, Kosaki R, Nakazawa A, Uemoto S, Noda M, Naiki Y and Horikawa R:
Living-donor liver transplantation for carbamoyl phosphate
synthetase 1 deficiency. Pediatr Transplant. 14:1036–1040.
2010.PubMed/NCBI View Article : Google Scholar
|